Skip to content

Basic Research on the Application of Viscoelastic Imaging Technology in Early Detection and Classification of breast cancer

Basic Research on the Application of Viscoelastic Imaging Technology in Early Detection and Classification of breast cancer - Application of Viscoelastic Imaging Technique in breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077015
Enrollment
Unknown
Registered
2023-10-26
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Gold Standard:Pathological results
Index test:Mindray Resona R9 ultrasound diagnostic instrument, STE elastic imaging, high-quality, STVI mode
Siemens MAGNETOM Vida 3.0T magnetic resonance, 18 channel breast imaging coil, THEA Devices elastic imaging instrument.

Sponsors

People's Hospital of Guangxi Zhuang Autonomous Region (Guangxi Academy of Medical Sciences)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
12 Years to 100 Years

Inclusion criteria

Inclusion criteria: Breast imaging report and data system BI-RADS 3-5, female patients with no contraindications to MRI or contrast agents, consent to relevant information collection, and complete multimodal ultrasound, CE-MRI, and MRE scans.

Exclusion criteria

Exclusion criteria: 1.The patient refused to participate in this study; 2. Patients who refuse ultrasound or MRI examination or are unable to undergo MRI examination due to metal foreign bodies in the body; 3. The patient has undergone breast surgery or neoadjuvant chemotherapy; 4. The patient has undergone breast biopsy before; 5. The patient refuses to undergo subsequent puncture or surgical treatment; 6. Previously suffering from other types of malignant tumors.

Design outcomes

Primary

MeasureTime frame
Ultrasonic viscoelastic parameters; Breast cancer microenvironment of TILs, sTILs, PD1/PD-L1, CNF;sensitivity;specificity;ROC curve;

Secondary

MeasureTime frame
MRE parameters;

Countries

China

Contacts

Public ContactHuang Xiaoli

People's Hospital of Guangxi Zhuang Autonomous Region (Guangxi Academy of Medical Sciences)

66583699@qq.com+86 136 6960 3700

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026